IL6 and myocardial infarction: By uncovering a novel regulatory pathway involving T cell-derived adenosine and fibroblast-mediated IL-6 formation, this study significantly enhances our understanding of MI-related inflammation and opens new avenues for targeted therapeutic interventions aimed at fine-tuning post-infarction inflammation.